The emergence of type 2 diabetes in young populations has mirrored a rising prevalence of obesity and insulin resistance during childhood and adolescence. At the same time, the role of adipokines as links between obesity and insulin resistance is becoming more appreciated. We sought to establish age-and sex-specific distributions of metabolic correlates of insulin resistance in healthy prepubertal children.
A key issue surrounding the current global rise in the prevalence of type 2 diabetes (T2D) 5 is the progressively younger age at presentation (1) (2) (3) (4) . The emergence of T2D in youth has mirrored a rising prevalence of obesity, insulin resistance, and its associated risk factors during childhood and adolescence (5) (6) (7) (8) (9) (10) (11) . Insulin resistance is known to play a key role in the pathogenesis of T2D (12 ) and related disorders (13 ) . Thus, recognition of the insulin resistance syndrome in childhood is becoming increasingly important. In parallel with the rising prevalence of obesity, insulin resistance, and T2D in children, there is a widening appreciation of the role of adipokines as regulators of energy metabolism (14 ) , links between obesity and insulin resistance (15) (16) (17) , and potential markers of cardiovascular disease (18 ) .
Although children may be screened for insulin resistance on the basis of clinical features such as obesity, acanthosis nigricans, and family history, identification of the metabolic correlates of insulin resistance requires laboratory assessment. The interpretation of laboratory data, however, presents a dilemma well known to pediatricians. The application of adult reference intervals in this context is inappropriate, yet appropriate age-and sex-specific pediatric data for comparison are scanty (19, 20 ) owing to the practical and ethical problems associated with collecting blood from large numbers of apparently healthy children to generate traditional reference values.
Here we present age-and sex-specific distributions of insulin, glucose, triglycerides, total and HDL cholesterol, urate, glycohemoglobin, sex hormonebinding globulin (SHBG), leptin, and adiponectin, based on analysis of fasting plasma samples collected from a cohort of 307 apparently healthy British children at school entry (mean age 4.9 years) and annually thereafter for 3 years. These 4 datasets constitute the first (prepubertal) phase of a nonintervention prospective cohort study (EarlyBird) that aims to establish which children are insulin resistant, and why. We also include the corresponding distributions of insulin sensitivity and ␤-cell function by homeostasis model assessment (HOMA) (21 ) , derived from glucose and insulin data. The detailed protocol for the EarlyBird study is described elsewhere (22 ) . Our data complement those presented previously (20 ) but differ in the younger age of our population and, crucially, in their longitudinal nature.
Materials and Methods

STUDY DESIGN
EarlyBird is a nonintervention prospective cohort study that is monitoring 307 children from school entry to the age of 16. Fifty-three of 71 primary schools in Plymouth, UK, agreed to participate in the study. From these, 28 were randomly selected from 4 groups stratified socioeconomically according to the proportion of pupils in each school entitled to free school meals (which are provided for lower income groups). The study follows the guidelines of the Helsinki Declaration of 1975 as revised in 1996 regarding the use of human subjects. It was approved by the Local Research Ethics Committee in 1999. The EarlyBird parents gave informed written consent before participation.
STUDY POPULATION
All 307 children (137 girls, 170 boys, mean age 4.9 years) were healthy at recruitment. Children known to have chronic illness or taking oral steroid medications were excluded. Body mass index (BMI) was derived from kg/m 2 and BMI standard deviation score (SDS) from UK 1990 centiles.
COLLECTION OF BLOOD SAMPLES
We followed recommendations for the collection of venous blood samples from children, with special relevance to the production of reference values (23 ) . All children attended a hospital-based outpatient facility at 0800 -0900 after an overnight fast of at least 10 h. Venous blood was collected with minimal stasis into Vacutainer Tubes (Becton Dickinson) and delivered to the laboratory within 2 h. After centrifugation (1500g for 10 min), samples were analyzed the same day or frozen at Ϫ20°C for not more than 1 week before analysis. We measured insulin, glucose, SHBG, triglycerides, total and HDL cholesterol, urate, and glycated hemoglobin directly and adiponectin and leptin after storage at Ϫ80°C.
ANALYTICAL METHODS
We assessed insulin sensitivity and ␤-cell function by HOMA 2, based on fasting insulin and glucose concentrations (21 ) . We measured insulin and SHBG by immunometric assay on a DPC Immulite analyzer, using kits manufactured by Diagnostic Products Corporation; glucose, cholesterol, HDL cholesterol, triglycerides, and urate on a Cobas Integra 700 analyzer (Roche Diagnostics); and glycohemoglobin by automated HPLC using a Menarini Biomen HA 8140 analyzer (Menarini Ltd). All of these analytes were subject to external quality control by UK National External Quality Assurance Schemes throughout the entire study period. We measured total adiponectin by RIA (Linco Research Inc.) and leptin by in-house RIA validated against the Linco assay for this analyte.
STATISTICAL ANALYSIS
Statistical analysis was carried out with SPSS software (version 14.0 from SPSS Inc). Distributions of triglycerides, adiponectin, leptin, and (in boys at 5-7 years) SHBG were skewed and were log-transformed before analysis; back-transformed values are shown in the tables. We used standard parametric and nonparametric techniques to identify outliers. For variables that were normally distributed, we defined results that were Ͼ3 SD from the mean as outliers and excluded them from analysis. For insulin and HOMA-%S, outliers were defined as Ͼ3 interquartile ranges above the upper quartile, since values below the analytical detection limit for insulin (2.5 mU/L) prevented normalization by logtransformation. For distributions that were normally distributed with or without log-transformation, we tabulated values corresponding to the 2.5th, 25th, 50th, 75th, and 97.5th centiles and calculated their 95% CIs. Centiles and their CIs for insulin and HOMA-%S were obtained using a nonparametric method in R (version 2.4.1, R Foundation for Statistical Computing) using a modification of the algorithm described by Hutson (24 ) . We used 1-way ANOVA to determine sex differences and paired t test to examine within-sex differences between 5 and 8 years.
Results
Mean age (SD) of both sexes at baseline was 4.9 (0.27) years. The follow-up interval was 12 (1.5) months. 
DISTRIBUTIONS
The distributions for all variables are shown in Table 1 . Insulin was significantly higher and insulin sensitivity (HOMA-%S) correspondingly lower in girls than in boys at all ages (P Յ 0.01 and Յ 0.04, respectively). Glucose was similar in boys and girls at 5 years (P ϭ 0.46), but thereafter was higher in girls. SHBG was lower in girls than in boys (P Յ 0.02). There were no significant sex differences in total cholesterol (P Ն 0.18), urate (P Ն 0.45), or glycated hemoglobin (P Ն 0.08), although HDL cholesterol was higher in boys than in girls. Leptin was significantly higher in girls than in boys at all ages (P Ͻ 0.001), whereas adiponectin was no different (P Ն 0.10) and SHBG was significantly lower (P Ͻ 0.01). Table 2 summarizes the trends observed in all variables in both sexes from 5 to 8 years and their associated statistical significance. BMI increased by 3.1% in the boys and 5.5% in the girls (P Ͻ 0.001). ␤-Cell function (HOMA-%B) decreased (Ϫ33%) and HOMA-%S increased (25%), but glucose also increased (8%) whereas HbA1c decreased (Ϫ4.4%). Consistent with the rise in insulin sensitivity, HDL cholesterol increased (15%) and triglycerides decreased (Ϫ5%). Adiponectin, on the other hand, decreased (Ϫ9%). The trends were similar in boys and girls. Table 3 summarizes the sex-specific mean BMI at each age and the BMI SDS. The P values relate to sex differences at each age.
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Discussion
The data tabulated here provide a unique set of ageand sex-specific distributions for metabolic variables in young children, which should be of use to professionals in laboratory medicine, pediatric clinicians, and researchers. The age distribution of the children is uniform, minimizing the risk of confounding by age-related effects. Similarly, the standardized sample collection procedure will have helped to minimize the influence of preanalytical sources of variation. Crucially, the data set is truly longitudinal, allowing trends to be tracked with confidence. The EarlyBird cohort represents a well-defined and phenotypically wellcharacterized group of children. The distributions are age-and sex-specific. Importantly, they are based on a population of healthy children, and so may provide insight into normal physiological changes and differences. In addition, we have included the mean BMI and sex-specific BMI SDS at each age, because insulin sensitivity is BMI dependent. The BMI SDS expresses deviation from the UK standards. The data reveal a number of trends and variations. Fasting insulin was higher (and HOMA-%S commensurately lower) in girls than in boys, at all ages. This may suggest a sex difference in insulin sensitivity, but further study is required to establish the significance of this observation. Girls also had higher concentrations of triglycerides and lower concentrations of HDL cholesterol and SHBG. The sex difference in fasting insulin persists after correction for anthropometric variables, physical activity, resting energy expenditure, and gonadotropin status (25 ) . We have speculated elsewhere on the wider significance of the sex differences we have observed (26 ) . Insulin sensitivity increases progressively in both sexes between 5 and 8 years, although it tends level off between 7 and 8 years. At the same time, fasting insulin, with which insulin sensitivity is inversely correlated, decreases. The increase in HDL cholesterol and tendency for triglycerides to decrease occur despite increasing BMI and BMI SDS. These trends are counterintuitive and illustrate powerfully the value of longitudinal data. We have discussed the relationships between adiposity and metabolic status in more detail elsewhere; although the trends between insulin resistance and fatness run in opposite directions, their correlation remains positive throughout (27 ) .
So what might explain these trends? A proliferation of adipocytes sufficient to increase their capacity to buffer dietary triglycerides, and thereby increase insulin sensitivity, is unlikely to be associated with an increase in glucose or decrease in adiponectin. On the other hand, a primary loss of ␤ cells would predict lower insulin, higher glucose, lower triglycerides, higher HDL cholesterol, and higher SHBG. The expected increase in BMI, reflecting the acquisition of fat in the years before puberty, may explain the decrease in adiponectin and increase in leptin, but may occur independently of the primary metabolic trends that were observed across the entire range of BMI (27 ) . Fasting glucose (and insulin) primarily reflect hepatic rather than peripheral insulin action. This may explain why glycohemoglobin, which registers total exposure to glucose rather than fasting alone, decreased while fasting glucose increased.
There are limitations and strengths to this study. The detection limit of the insulin assay precluded its measurement in some of the samples, although none of the metabolic trends was different in such children compared with the cohort as a whole. The cohort is largely white and confined to the city of Plymouth, UK. We were nevertheless careful to randomize the children over a wide socioeconomic range, and a post hoc analysis using the index of multiple deprivation gave a mean score of 21.7 (range 6.5-73.0), similar to the UK mean of 26.3. The major strengths of the study are the size of the cohort, its age uniformity, and its truly longitudinal design.
In summary, we offer a set of age-and sex-specific distributions for metabolic variables in contemporary prepubertal children. These indicate that sex differences in insulin resistance and its metabolic correlates have already become apparent by 5 years and persist in the years leading up to puberty. Metabolic health, for reasons that are not clear, appears to improve in both sexes from 5 to 8 years despite increasing adiposity, increasing leptin, and decreasing adiponectin. 
